Literature DB >> 9920352

Effects of sex steroids on proliferation in normal mammary tissue.

G Söderqvist1.   

Abstract

Numerous women are treated with a combination of oestrogen and progestogen for contraception and hormone replacement therapy worldwide. A possible increased risk of cancer in target organs has been discussed vividly for many years. While oestrogens are clearly mitogenic for breast epithelial cells, there has been considerable uncertainty about the effects of progestogens. This article reviews current knowledge on this field, including our own data. Oestrogen receptors are down-regulated during the luteal phase, while progesterone receptors remain at a high level throughout the menstrual cycle. According to most studies, in vivo proliferation of normal breast epithelial cells is higher during the luteal phase in the vast majority of women. Normal breast tissue can convert oestrone sulphate to oestradiol. A negative correlation between the levels of circulating oestradiol and the enzyme converting oestrone into oestradiol suggests a local regulatory mechanism of tissue oestradiol formation. Serum progesterone levels correlate positively with sulphatase activity while 19-norsteroid progestogens may be inhibitory. We found that long-term continuous combined hormonal treatment with conjugated equine oestrogens and medroxyprogesterone acetate induced a proliferative response in the breasts of surgically postmenopausal macaques. The effect of combined treatment was more pronounced than that of oestrogen treatment alone. Both endogenous progesterone and exogenous progestogens increase proliferation of breast epithelial cells. Exogenous progestogens down-regulate both oestrogen and progesterone receptors. Oestrogen and progestogens may have both direct and indirect stimulating effects on proliferation. The finding of a positive correlation between insulin-like growth factor I messenger RNA and proliferation found in hormonally treated women with low receptor levels suggests the possibility of nonreceptor-mediated effects of sex steroids on proliferation, which needs to be investigated further.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9920352

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  11 in total

1.  Estrogen receptors ER alpha and ER beta in proliferation in the rodent mammary gland.

Authors:  Guojun Cheng; Zhang Weihua; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

Review 2.  Challenges to defining a role for progesterone in breast cancer.

Authors:  Carol A Lange
Journal:  Steroids       Date:  2007-12-28       Impact factor: 2.668

Review 3.  Progesterone and breast cancer.

Authors:  Carol A Lange; Douglas Yee
Journal:  Womens Health (Lond)       Date:  2008-03

Review 4.  TRIENNIAL LACTATION SYMPOSIUM/BOLFA: Dietary regulation of allometric ductal growth in the mammary glands.

Authors:  G E Berryhill; J F Trott; A L Derpinghaus; R C Hovey
Journal:  J Anim Sci       Date:  2017-12       Impact factor: 3.159

5.  Photoinduced Carboborative Ring Contraction Enables Regio- and Stereoselective Synthesis of Multiply Substituted Five-Membered Carbocycles and Heterocycles.

Authors:  Shengfei Jin; Vu T Nguyen; Hang T Dang; Dat P Nguyen; Hadi D Arman; Oleg V Larionov
Journal:  J Am Chem Soc       Date:  2017-08-09       Impact factor: 15.419

Review 6.  Estrogen metabolism and breast cancer.

Authors:  Hamed Samavat; Mindy S Kurzer
Journal:  Cancer Lett       Date:  2014-04-28       Impact factor: 8.679

7.  Late age at first full term birth is strongly associated with lobular breast cancer.

Authors:  Polly A Newcomb; Amy Trentham-Dietz; John M Hampton; Kathleen M Egan; Linda Titus-Ernstoff; Shaneda Warren Andersen; E Robert Greenberg; Walter C Willett
Journal:  Cancer       Date:  2010-11-10       Impact factor: 6.860

8.  Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry.

Authors:  Fernando P Filgueira; Núbia S Lobato; Denise L Nascimento; Graziela S Ceravolo; Fernanda R C Giachini; Victor V Lima; Ana Paula Dantas; Zuleica B Fortes; R Clinton Webb; Rita C Tostes; Maria Helena C Carvalho
Journal:  Steroids       Date:  2018-11-17       Impact factor: 2.668

Review 9.  Progesterone receptors--animal models and cell signalling in breast cancer. Implications for breast cancer of inclusion of progestins in hormone replacement therapies.

Authors:  Catherine Schairer
Journal:  Breast Cancer Res       Date:  2002-10-07       Impact factor: 6.466

10.  Birth intervals and breast cancer risk.

Authors:  A Kauppila; P Kyyrönen; M Hinkula; E Pukkala
Journal:  Br J Cancer       Date:  2009-09-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.